289 related articles for article (PubMed ID: 23122991)
1. First year experience of rotavirus immunisation programme in Finland.
Leino T; Ollgren J; Salo H; Tiihonen P; Kilpi T
Vaccine; 2012 Dec; 31(1):176-82. PubMed ID: 23122991
[TBL] [Abstract][Full Text] [Related]
2. Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare.
Leino T; Baum U; Scott P; Ollgren J; Salo H
Vaccine; 2017 Oct; 35(42):5611-5617. PubMed ID: 28893475
[TBL] [Abstract][Full Text] [Related]
3. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
[TBL] [Abstract][Full Text] [Related]
4. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
Hemming-Harlo M; Gylling A; Herse F; Haavisto I; Nuutinen M; Pasternack M; Kanibir MN; Hartwig S; Carias C
Vaccine; 2022 Jun; 40(29):3942-3947. PubMed ID: 35641360
[TBL] [Abstract][Full Text] [Related]
5. Burden of rotavirus gastroenteritis and potential benefits of a pentavalent rotavirus vaccination in Belgium.
Dhont P; Trichard M; Largeron N; Rafia R; Bénard S
J Med Econ; 2008; 11(3):431-48. PubMed ID: 19450097
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
Clarke MF; Davidson GP; Gold MS; Marshall HS
Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665
[TBL] [Abstract][Full Text] [Related]
7. Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France.
Huet F; Largeron N; Trichard M; Miadi-Fargier H; Jasso-Mosqueda G
Vaccine; 2007 Aug; 25(34):6348-58. PubMed ID: 17629598
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
[TBL] [Abstract][Full Text] [Related]
9. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
[TBL] [Abstract][Full Text] [Related]
10. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan.
Yoshikawa T; Matsuki T; Sato K; Mizuno M; Shibata M; Hasegawa S; Morita M; Iwasa M; Gopala K; Holl K
Vaccine; 2018 Jan; 36(4):527-534. PubMed ID: 29248263
[TBL] [Abstract][Full Text] [Related]
11. Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations.
Givon-Lavi N; Ben-Shimol S; Cohen R; Greenberg D; Dagan R
Vaccine; 2015 Apr; 33(16):1934-40. PubMed ID: 25744226
[TBL] [Abstract][Full Text] [Related]
12. Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector.
Trimis G; Koutsoumbari I; Kottaridi C; Palaiologou N; Assimakopoulou E; Spathis A; Lebessi E; Konstantopoulos A; Kafetzis D; Karakitsos P; Papaevangelou V
Vaccine; 2011 Oct; 29(43):7292-5. PubMed ID: 21816195
[TBL] [Abstract][Full Text] [Related]
13. Impact of the introduction of rotavirus vaccination on paediatric hospital admissions, Lothian, Scotland: a retrospective observational study.
Forrest R; Jones L; Willocks L; Hardie A; Templeton K
Arch Dis Child; 2017 Apr; 102(4):323-327. PubMed ID: 27806968
[TBL] [Abstract][Full Text] [Related]
14. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
Tapia MD; Armah G; Breiman RF; Dallas MJ; Lewis KD; Sow SO; Rivers SB; Levine MM; Laserson KF; Feikin DR; Victor JC; Ciarlet M; Neuzil KM; Steele AD
Vaccine; 2012 Apr; 30 Suppl 1():A79-85. PubMed ID: 22520141
[TBL] [Abstract][Full Text] [Related]
15. Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.
Hartwig S; Uhari M; Renko M; Bertet P; Hemming M; Vesikari T
BMC Health Serv Res; 2014 Dec; 14():632. PubMed ID: 25494641
[TBL] [Abstract][Full Text] [Related]
16. RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe.
Vesikari T; Itzler R; Karvonen A; Korhonen T; Van Damme P; Behre U; Bona G; Gothefors L; Heaton PM; Dallas M; Goveia MG
Vaccine; 2009 Dec; 28(2):345-51. PubMed ID: 19879226
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.
Muhsen K; Anis E; Rubinstein U; Kassem E; Goren S; Shulman LM; Ephros M; Cohen D
Clin Microbiol Infect; 2018 Jan; 24(1):53-59. PubMed ID: 28442435
[TBL] [Abstract][Full Text] [Related]
18. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD
Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
[TBL] [Abstract][Full Text] [Related]
19. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
[TBL] [Abstract][Full Text] [Related]
20. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.
Tafalla M; Gardovska D; Gopala K; Kozlovska L
Hum Vaccin Immunother; 2019; 15(6):1272-1278. PubMed ID: 30335570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
